Cargando…

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment

BACKGROUND: Anaplastic thyroid cancer (ATC) is among the most aggressive human malignancies, with a mean survival time of 6 months regardless of the treatment. METHODS: This retrospective study used the single-centre database system of the Gangnam Severance Hospital. The management and outcome data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Haejun, Kim, Soo Young, Kim, Seok-Mo, Chang, Ho-Jin, Lee, Yong Sang, Park, Cheong Soo, Chang, Hang-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797284/ https://www.ncbi.nlm.nih.gov/pubmed/35117908 http://dx.doi.org/10.21037/tcr-20-1364

Ejemplares similares

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
por: Lee, Jin-Seok, et al.
Publicado: (2022)

Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020)

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]
por: Park, Ki Cheong, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma: A Therapeutic Dilemma
por: Chang, Hang-Seok, et al.
Publicado: (2005)

Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
por: Kim, Soo Young, et al.
Publicado: (2020)

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
por: Hussain, Nasir, et al.
Publicado: (2013)

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019)

Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2018)

Solitary lateral neck node metastasis in papillary thyroid carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2014)

Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
por: Kim, Seok-Mo, et al.
Publicado: (2020)

Aggressiveness of Differentiated Thyroid Carcinoma in Pediatric Patients Younger Than 16 years: A Propensity Score-Matched Analysis
por: Kim, Soo Young, et al.
Publicado: (2022)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

New approach of prediction of recurrence in thyroid cancer patients using machine learning
por: Kim, Soo Young, et al.
Publicado: (2021)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Overcoming the Limitations of Fine Needle Aspiration Biopsy: Detection of Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma
por: Jun, Hak Hoon, et al.
Publicado: (2015)

Cervical bronchogenic cysts mimic metastatic lymph nodes during thyroid cancer surgery
por: Jun, Hak Hoon, et al.
Publicado: (2014)

The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer
por: Chang, Hojin, et al.
Publicado: (2015)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2023)

Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

A case of Riedel's thyroiditis
por: Pi, Gyu Young, et al.
Publicado: (2012)

Relationship between Negative Mental Adjustment to Cancer and Distress in Thyroid Cancer Patients
por: Seok, Jeong-Ho, et al.
Publicado: (2013)

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()
por: Lee, Yong Sang, et al.
Publicado: (2018)

Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy
por: Kim, Bup-Woo, et al.
Publicado: (2017)

On-site ultrasound-guided localization for impalpable nodal recurrences in papillary thyroid carcinoma patients
por: Kim, Kuk-Jin, et al.
Publicado: (2013)

Difficult evaluation of thyroid cancer due to cervical paraffin injection
por: Lee, Yong Sang, et al.
Publicado: (2011)

Prognostic Role of Pre-Treatment [(18)F]FDG PET/CT in Patients with Anaplastic Thyroid Cancer
por: Kim, Hyun Jeong, et al.
Publicado: (2021)

Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
por: Lim, Sun Min, et al.
Publicado: (2012)

Coexistence of parathyroid adenoma and papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2011)

Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer
por: Hwang, Yeseong, et al.
Publicado: (2023)

Clinicopathological and Genetic Characteristics of Patients of Different Ages with Diffuse Sclerosing Variant Papillary Thyroid Carcinoma
por: Kim, Soo-Young, et al.
Publicado: (2023)

Prophylactic antibiotics may not be necessary for transoral endoscopic thyroidectomy
por: Lee, Jun Sung, et al.
Publicado: (2022)

Postoperative Complications of Thyroid Cancer in a Single Center Experience
por: Lee, Yong Sang, et al.
Publicado: (2010)

Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases
por: Shin, Dong-Won, et al.
Publicado: (2020)

Impact of Postthyroidectomy Scar on the Quality of Life of Thyroid Cancer Patients
por: Choi, Yuri, et al.
Publicado: (2014)

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer
por: Kim, Seok-Mo, et al.
Publicado: (2015)

Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma
por: Cho, Seomin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q09gft29bpm5503igp63073ff1